CA2989394C - A novel process for the preparation of teriflunomide - Google Patents
A novel process for the preparation of teriflunomide Download PDFInfo
- Publication number
- CA2989394C CA2989394C CA2989394A CA2989394A CA2989394C CA 2989394 C CA2989394 C CA 2989394C CA 2989394 A CA2989394 A CA 2989394A CA 2989394 A CA2989394 A CA 2989394A CA 2989394 C CA2989394 C CA 2989394C
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- water
- process according
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/14—Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/32—Separation; Purification; Stabilisation; Use of additives
- C07C253/34—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
- C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
- G01N23/20075—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials by measuring interferences of X-rays, e.g. Borrmann effect
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3028/CHE/2015 | 2015-06-17 | ||
| IN3028CH2015 | 2015-06-17 | ||
| PCT/IB2016/053556 WO2016203410A1 (en) | 2015-06-17 | 2016-06-16 | A novel process for the preparation of teriflunomide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2989394A1 CA2989394A1 (en) | 2016-12-22 |
| CA2989394C true CA2989394C (en) | 2023-08-01 |
Family
ID=57545389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2989394A Active CA2989394C (en) | 2015-06-17 | 2016-06-16 | A novel process for the preparation of teriflunomide |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10526279B2 (https=) |
| EP (1) | EP3310755B1 (https=) |
| JP (1) | JP6797839B2 (https=) |
| KR (1) | KR102719583B1 (https=) |
| AU (1) | AU2016280243B2 (https=) |
| BR (1) | BR112017027175B1 (https=) |
| CA (1) | CA2989394C (https=) |
| ES (1) | ES2870205T3 (https=) |
| MX (1) | MX2017016192A (https=) |
| RU (1) | RU2722316C2 (https=) |
| WO (1) | WO2016203410A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116924938B (zh) * | 2022-04-02 | 2025-10-31 | 江苏康缘药业股份有限公司 | 一种特立氟胺的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE634286C (de) | 1935-02-23 | 1936-08-26 | Hoffmann La Roche & Co Akt Ges | Verfahren zur Herstellung dialkylsubstituierter Amide von Isoxazolcarbonsaeuren |
| NL186239B (nl) * | 1975-06-05 | Hoechst Ag | Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze. | |
| US5268382A (en) | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
| ES2102367T3 (es) * | 1990-05-18 | 1997-08-01 | Hoechst Ag | Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion. |
| ES2237553T3 (es) * | 2000-02-15 | 2005-08-01 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la sintesis de leflunomida. |
| US6727272B1 (en) * | 2002-07-15 | 2004-04-27 | Unitech Pharmaceuticals, Inc. | Leflunomide analogs for treating rheumatoid arthritis |
| CA2724861A1 (en) * | 2008-06-05 | 2009-12-10 | Alembic Limited | A process for preparing teriflunomide |
| CN101817798B (zh) * | 2009-02-26 | 2014-04-16 | 江苏亚邦爱普森药业有限公司 | 制备来氟米特的绿色工艺 |
| WO2012110911A1 (en) * | 2011-02-18 | 2012-08-23 | Alembic Pharmaceuticals Limited | Novel polymorphic form of teriflunomide |
| WO2015029063A2 (en) * | 2013-08-30 | 2015-03-05 | Msn Laboratories Private Limited | Novel polymorph of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethyl phenyl)-amide and process for the preparation thereof |
-
2016
- 2016-06-16 US US15/736,981 patent/US10526279B2/en active Active
- 2016-06-16 BR BR112017027175-3A patent/BR112017027175B1/pt active IP Right Grant
- 2016-06-16 KR KR1020187000970A patent/KR102719583B1/ko active Active
- 2016-06-16 AU AU2016280243A patent/AU2016280243B2/en active Active
- 2016-06-16 CA CA2989394A patent/CA2989394C/en active Active
- 2016-06-16 ES ES16811119T patent/ES2870205T3/es active Active
- 2016-06-16 JP JP2017565042A patent/JP6797839B2/ja active Active
- 2016-06-16 RU RU2017145967A patent/RU2722316C2/ru active
- 2016-06-16 WO PCT/IB2016/053556 patent/WO2016203410A1/en not_active Ceased
- 2016-06-16 MX MX2017016192A patent/MX2017016192A/es active IP Right Grant
- 2016-06-16 EP EP16811119.3A patent/EP3310755B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3310755A4 (en) | 2019-02-27 |
| RU2722316C2 (ru) | 2020-05-29 |
| MX2017016192A (es) | 2018-06-19 |
| KR102719583B1 (ko) | 2024-10-18 |
| EP3310755A1 (en) | 2018-04-25 |
| BR112017027175B1 (pt) | 2022-02-08 |
| JP2018517733A (ja) | 2018-07-05 |
| BR112017027175A2 (https=) | 2017-12-15 |
| CA2989394A1 (en) | 2016-12-22 |
| AU2016280243A1 (en) | 2018-01-18 |
| WO2016203410A1 (en) | 2016-12-22 |
| ES2870205T3 (es) | 2021-10-26 |
| JP6797839B2 (ja) | 2020-12-09 |
| RU2017145967A (ru) | 2019-07-18 |
| KR20180018697A (ko) | 2018-02-21 |
| AU2016280243B2 (en) | 2020-12-03 |
| US10526279B2 (en) | 2020-01-07 |
| RU2017145967A3 (https=) | 2019-12-06 |
| US20180170859A1 (en) | 2018-06-21 |
| EP3310755B1 (en) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6392436B2 (ja) | 置換された5−フルオロ−1h−ピラゾロピリジン類を製造するための方法 | |
| JP5652628B2 (ja) | 2−アミノ−n−(2,2,2−トリフルオロエチル)アセトアミド化合物又はその塩の製造方法 | |
| JP2017503843A (ja) | N−[(3−アミノオキセタン−3−イル)メチル]−2−(1,1−ジオキソ−3,5−ジヒドロ−1,4−ベンゾチアゼピン−4−イル)−6−メチル−キナゾリン−4−アミンの製造のための方法 | |
| KR102523786B1 (ko) | 트리아졸로피리딘 화합물의 제조 방법 | |
| WO2011004402A2 (en) | Improved process for the preparation of ambrisentan and novel intermediates thereof | |
| WO2014020555A2 (en) | An improved process for the preparation of dabigatran etexilate mesylate | |
| CN107922352A (zh) | 制备蛋白质脱乙酰酶抑制剂的方法 | |
| US20220259204A1 (en) | A process for the preparation of venetoclax and its polymorphs thereof | |
| EP2978750B1 (en) | "synthesis of dabigatran" | |
| CA2989394C (en) | A novel process for the preparation of teriflunomide | |
| JP6781030B2 (ja) | L−カルノシン誘導体またはその塩、及びl−カルノシンまたはその塩の製造方法 | |
| DK2630118T3 (en) | SYNTHESIS OF aliskiren | |
| WO2019208807A1 (ja) | 芳香族ニトリル化合物の製造方法 | |
| CN105189467A (zh) | 制备哒嗪酮化合物的方法 | |
| DE2450617A1 (de) | Thiazolderivate, ihre salze, verfahren zu ihrer herstellung und arzneimittel | |
| CN101160288B (zh) | 烟酸衍生物或其盐的制造方法 | |
| Wu∗ | A facile synthesis of 5-amino-3-trifluoromethyl-4-methoxycarbonylisoxazole | |
| CN112321538A (zh) | 一种合成单胺保护的哌嗪-(r/s)2-甲酸酯的方法 | |
| WO2012165651A1 (ja) | ベンジルアミン化合物を製造する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210518 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250430 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250430 |